Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL129722 | 0.95 | TSHR (0.53) | TSHRALDH1A1ADH1CADH1A | |
| Tetrahydrofuran SCHEMBL28743802 | 0.92 | TSHR (0.50) | TSHRALDH1A1ADH1CADH1A | |
| Dimethylformamide SCHEMBL1072443 | 0.92 | TSHR (0.50) | TSHRALDH1A1ADH1CADH1A | |
| Tetrahydrofuran SCHEMBL23295002 | 0.90 | TSHR (0.43) | TSHRALDH1A1 | |
| Dioxane SCHEMBL28817546 | 0.89 | TSHR (0.53) | TSHR | |
| Tetrahydrofuran SCHEMBL16837095 | 0.87 | TSHR (0.45) | TSHRALDH1A1ADH1CADH1A | |
| Tetrahydrofuran SCHEMBL10905548 | 0.87 | TSHR (0.45) | TSHRALDH1A1ADH1CADH1A | |
| Tetrahydrofuran SCHEMBL28212755 | 0.86 | TSHR (0.39) | TSHRALDH1A1 | |
| Tetrahydrofuran SCHEMBL9439653 | 0.86 | TSHR (0.39) | TSHRALDH1A1 | |
| Dimethylformamide SCHEMBL6550357 | 0.86 | TSHR (0.39) | TSHRALDH1A1ADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120107273-A1 | NEW PIPERAZINE COMPOUND AND USE THEREOF AS A HCV POLYMERASE INHIBITOR | JAPAN TOBACCO INC. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-8017612-B2 | therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors | JAPAN TOBACCO INC. (JP) | 2011-09-13 | — | — | US | disclosed |
| EP-2009004-A1 | NOVEL PIPERAZINE COMPOUND, AND USE THEREOF AS HCV POLYMERASE INHIBITOR | Japan Tobacco, Inc. (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-20080081818-A1 | therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors | JAPAN TOBACCO INC. (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20080081789-A1 | BETA PEPTOIDS WITH ANTIMICROBIAL ACTIVITY | SHUEY STEVEN W | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081818-A1 | therapeutic agent for hepatitis C; R)-4-(4-trifluoromethyl-benzenesulfonyl)-piperazine-1,3-dicarboxylic acid 3-(4-isopropyl-benzylamide) 1-pyridin-4-ylamide; enzyme inhibitors | HAVCR2, AADAC, DNPEP | TSHR 3775/4885ALDH1A1 96/4885ADH1C 28/4885 |
| US-20080081789-A1 | BETA PEPTOIDS WITH ANTIMICROBIAL ACTIVITY | PEPD, VIP, CLPP | TSHR 3406/4885ALDH1A1 4496/4885ADH1C 3827/4885 |
| US-20120107273-A1 | NEW PIPERAZINE COMPOUND AND USE THEREOF AS A HCV POLYMERASE INHIBITOR | POLR1C, POLR2E, POLR2H | TSHR 4735/4885ALDH1A1 557/4885ADH1C 78/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.